PEPG

Conviction 22HealthcareScan · Thu, Jun 25, 2026

Three outside down

PEPG$1.71-3.39%

ResistanceSupportVol 14Insider sell

Vol MA14 696.39K

Mar 26Apr 14May 1May 19Jun 8Jun 25

PepGen Inc.PHARMACEUTICAL PREPARATIONSwww.pepgen.com ↗

Price1.71

Change-3.39%

Gap-0.85%

Rel volume0.52×

Avg volume659.15K

Avg $ vol1.04M

SMA 201.55

SMA 501.61

SMA 2004.06

Price vs 50+6.51%

Price vs 200-57.90%

MA stackmixed

50/200 cross—

Supertrendup · 1.53

RSI (14)54

MACD hist0.06

MACD cross—

Stoch %K / %D62 / 70

ADX (14)26

+DI / −DI28 / 16

RSI divergenceBullish

MACD divergence—

ATR %+7.13%

ADR %6.20%

52w high7.17

52w low1.01

From 52w high-76.15%

Above 52w low+69.31%

New 52w highNo

SqueezeOff

Bollinger width39.73%

%B0.75

Donchian pos61.61%

Donchian high1.96

Donchian low1.31

AVWAP (52w high)3.05

vs AVWAP high-43.99%

AVWAP (52w low)4.18

vs AVWAP low-59.11%

OBV trendUp

Chaikin MF (20)-0.13

Today vs 20d0.52×

Avg vol (14d)696.39K

Avg vol (20d)659.15K

Avg $ vol (20d)1.04M

Market cap118.28M

RS 3m (vs SPY)-74.76%

RS 6m (vs SPY)-75.08%

RS line new highNo

Trend template3/8

Technical rank31.2

1 week+0.59%

1 month+11.76%

3 months-64.96%

6 months-68.57%

1 year+23.02%

YTD-76.15%

P/E-1.32

P/B0.88

P/S—

P/FCF-1.44

EPS-2.12

Div yield—

ROE-66.92%

ROA-57.36%

Debt/Eq—

Current14.98

EV/EBITDA-0.83

Gross margin—

Net margin—

Rev growth—

EPS growth0.36%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value76.13M

Revenue—

Net income-17.76M

Gross profit—

Free cash flow-81.9M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out69.17M

Employees59

ListedFri, May 6, 2022

Free float38.43M

Float %55.9%

Short interest3.75M

Days to cover5.5d

Short volume51.5%

Squeeze score52 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.30 · 5 est

Last EPS vs est−$0.26 vs −$0.31

Last surprise+16.1% beat

Setup gradeD

Conviction22 / 100

Pattern quality—

Tech rank31.2 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree outside down

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PEPG

All disclosures →

No recent disclosed trades by Congress in PEPG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PEPG · 8 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Wyman Lisa Director · Stock Option (Right to Buy) · 2026-06-18	Grant	34K	—	2026-06-18	2026-06-22
Resnick Joshua Director · Stock Option (Right to Buy) · 2026-06-18	Grant	34K	—	2026-06-18	2026-06-22
Mayer Howard Director · Stock Option (Right to Buy) · 2026-06-18	Grant	34K	—	2026-06-18	2026-06-22
Finer Mitchell H. Director · Stock Option (Right to Buy) · 2026-06-18	Grant	34K	—	2026-06-18	2026-06-22
HENSON HEIDI Director · Stock Option (Right to Buy) · 2026-06-18	Grant	34K	—	2026-06-18	2026-06-22
Dable Habib J Director · Stock Option (Right to Buy) · 2026-06-18	Grant	34K	—	2026-06-18	2026-06-22
KEATING LAURIE Director · Stock Option (Right to Buy) · 2026-06-18	Grant	34K	—	2026-06-18	2026-06-22
RA CAPITAL MANAGEMENT, L.P. Director · Stock Option (Right to Buy) · 2026-06-18	Grant	34K	—	2026-06-18	2026-06-22
Kasraian Kasra Chief Technical Officer · Common Stock · 2026-05-21	Sell	1.23K	$2K	2026-05-21	2026-05-26

SEC filings

EDGAR filings in PEPG · 1 recent

EDGAR →

8-K8-KMon, Jun 22, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.